Hourglass Capital’s Cardinal Health CAH Stock Holding History

Hourglass Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,650	Closed	-$829K	–	135
2021 Q1	$829K	Buy	+13,650	New	+$753K	0.21%	82

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hourglass Capital's CAH Position: Q2 2021 in Review

Hourglass Capital sold out of Cardinal Health (CAH) in Q2 2021, closing a stake of 13,650 shares — an estimated $829K sold.

Hourglass Capital first reported a position in CAH in Q1 2021 and held it in 1 quarter. The position peaked at $829K in Q1 2021. 789 funds tracked by Wall St. Rank hold CAH as of Q2 2021.

Hourglass Capital reported no remaining Cardinal Health position as of Q2 2021 after selling out during the quarter.
Hourglass Capital sold 13,650 Cardinal Health shares in Q2 2021, an estimated $829K.
Hourglass Capital first reported a position in Cardinal Health in Q1 2021 and held it in 1 quarter.
Hourglass Capital's Cardinal Health position peaked at $829K in Q1 2021.
789 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2021.

Based on Hourglass Capital's 13F filing for Q2 2021, filed 12 Aug 2021.